COMMUNIQUÉS West-GlobeNewswire

Bellicum Announces Data Presentations on Lead Product Candidate Rivo-cel and Controllable CAR Program at the 60th American Society of Hematology Annual Meeting
01/11/2018
Nine abstracts accepted, including two oral presentations HOUSTON, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for [...]
BeiGene to Present Clinical Data on Tislelizumab and Zanubrutinib at the 60th American Society of Hematology Annual Meeting
01/11/2018
Company to Host Investor Meeting and Webcast on Monday, December 3, at 8 pm PST CAMBRIDGE, Mass. and BEIJING, China, Nov. 01, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE), a commercial-stage biopharmaceutical [...]
Progressive Care Inc. CEO to Speak at 5th Annual Florida Telehealth Summit in St. Pete Beach, Florida
01/11/2018
MIAMI, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that the company will be attending and speaking at the 5th [...]
Konica Minolta Provides New Insights with AeroRemote® Insights
01/11/2018
WAYNE, N.J., Nov. 01, 2018 (GLOBE NEWSWIRE) -- At RSNA 2018, Konica Minolta Healthcare Americas, Inc. will showcase new advancements of the AeroRemote platform. AeroRemote Insights is a comprehensive performance [...]
Forty Seven Inc. to Present New Preclinical Data on 5F9 at the 60th American Society of Hematology (ASH) Annual Meeting
01/11/2018
-- 5F9 Priming Dose Results in CD47 Pruning, Removing CD47 from Surface of Red Blood Cells to Mitigate Risk of Anemia -- -- 5F9 Demonstrates Synergy in Combination with Azacitidine in Acute Myeloid Leukemia (AML) Models [...]
Kura Oncology Announces Upcoming Presentations at ASH Annual Meeting
01/11/2018
SAN DIEGO, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that two [...]
Miragen Therapeutics to Present New Cobomarsen Phase 1 Clinical Trial Data at the 2018 American Society of Hematology Annual Meeting
01/11/2018
BOULDER, Colo., Nov. 01, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced [...]
Plus Products: Top-Ranked Edibles in California -- CFN Media
01/11/2018
SEATTLE, Nov. 01, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
ATW Tech Closes the Sale of its Atman Assets for $1.3 Million
01/11/2018
MONTREAL, Nov. 01, 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (TSX-V: ATW) announces today the closing of the sale of its Psychometric Research and Services of Atman assets (“Atman”), previously announced on September 17, [...]
ATW Tech conclut la vente des actifs d’Atman pour 1,3 million
01/11/2018
MONTRÉAL, 01 nov. 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (la « Société » ou « ATW Tech ») (TSX-V : ATW) annonce aujourd’hui la clôture de la vente de ses actifs des Services et Recherche Psychométrique d‘Atman (« Atman [...]
GBT Announces Upcoming Data Presentations at 60th American Society of Hematology (ASH) Annual Meeting & Exposition
01/11/2018
Company to Present Three Oral Presentations, Including Results Beyond 12 Weeks from Part A of the HOPE Study Company to Host Investor Webcast on Monday, December 3 SOUTH SAN FRANCISCO, Calif., Nov. 01, 2018 (GLOBE [...]
Terra Tech Corp. Makes Strategic Investment in Leading Hydroponics Provider
01/11/2018
IRVINE, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp. (OTCQX: TRTC), (“Terra Tech” or the “Company”) a vertically integrated cannabis-focused agriculture company, is pleased to announce that it has made a $ [...]
Onconova Therapeutics, Inc. to Provide Corporate Update and Third Quarter 2018 Financial Results
01/11/2018
Company to Hold Conference Call and Webcast at 9:00 a.m. Eastern Time on Tuesday, November 13, 2018 NEWTOWN, Pa., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) , a Phase 3-stage [...]
Eyenovia Announces Conference Call and Webcast for Third Quarter 2018 Financial Results
01/11/2018
NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to deliver microdosed [...]
ChemoCentryx to Hold Third Quarter 2018 Financial Results Conference Call on Thursday, November 8, 2018
01/11/2018
MOUNTAIN VIEW, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's third quarter 2018 financial results will be released after market close on Thursday, [...]
Daxor Corporation Initiates Strategic Collaboration with CHF Solutions, Inc. to Manage Patients with Fluid Overload
01/11/2018
NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- DAXOR CORPORATION ( NYSE MKT: DXR ) announced today that it has entered into an agreement with CHF Solutions (Nasdaq: CHFS) to explore clinical synergies between the company’s [...]
Vericel to Present at the Canaccord Genuity Medical Technologies & Diagnostic Forum
01/11/2018
CAMBRIDGE, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, [...]
Sirona Dx Introduces Imaging Mass Cytometry Services to Advance Biomarker Discovery and Therapeutic Development
01/11/2018
Specialized CRO offers high-definition tissue imaging services for pharmaceutical and clinical research SOUTH SAN FRANCISCO, Calif. and PORTLAND, Ore., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Sirona Dx, a leader in high- [...]
Viveve to Host Conference Call to Discuss Third Quarter 2018 Financial and Operating Results
01/11/2018
ENGLEWOOD, Colo., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women's intimate health, today announced that it will report financial results for the [...]

Pages